ReviewIndian journal of thoracic and cardiovascular surgery2022
Pulmonary sclerosing pneumocytoma-a case series.
Review in Indian journal of thoracic and cardiovascular surgery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Symptomatic Sclerosing Pneumocytoma of Lung: A Diagnostic Challenge with Diverse Morphological Patterns.Iranian journal of pathology · 2026Article
- A Sheep in Wolf's Clothing: Pulmonary Sclerosing Pneumocytoma Mimicking Malignant Neoplasm.Annals of thoracic surgery short reports · 2026Article
- Pulmonary sclerosing pneumocytoma with lymph node metastasis and highJournal of Zhejiang University. Science. B · 2026Review
- Clinicopathological characteristics of alveolar adenoma.Frontiers in oncology · 2026Article
- A potential new entity pending further validation of pulmonary primary interstitial Tumor: Lymphangioleiomyomatosis-like.Respiratory medicine case reports · 2025Article
- Navigating the diagnostic maze: the challenge of sclerosing pneumocytoma in frozen sections.International journal of clinical and experimental pathology · 2024Article
- An overview on the principles of management of haemoptysis.Indian journal of thoracic and cardiovascular surgery · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pulmonary sclerosing pneumocytoma (PSP) is a rare and interesting pulmonary tumour that presents a diagnostic challenge to the surgeon due to its bland symptomatology, indolent course, non-specific radiological features and ambiguous histopathological findings, which could lead to errors in management and prognostication. Herein, we present a series of 4 patients with PSP who were managed in our institution over a period of 8 years and briefly discuss relevant literature.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.